An organic compound that acts as an antioxidant may help some people with multiple sclerosis walk a little better.
Researchers at Oregon Health and Science University (OHSU) report that a small study has revealed that daily doses of 1,200 mg of alpha-lipoic acid may help some multiple sclerosis (MS) patients with their gait.
After two years in the randomized, double-blind study, those that took the supplement maintained walking speeds but those on the placebo deteriorated.
“This small study showed modest benefit to help understand gait and balance effect,” Kathy Costello, associate vice president of healthcare access at the National Multiple Sclerosis Society, told Healthline.
“Walking is very important and without balance it’s difficult. These are measures that seem to get at what’s needed for people to be mobile,” she said.
Alpha-lipoic acid is naturally found in low levels of some foods, including dark leafy greens, broccoli, yams, potatoes, red meat, and organ meat. It’s also available as an over-the-counter supplement.
“Alpha-lipoic acid is an interesting supplement. It has properties that may be beneficial to MS,” Costello said. “We’re not 100 percent clear, but human and animal studies have shown some benefit.”
She and other experts said they were encouraged by the study, but they cautioned it’s still early in this research phase.
“I don’t recommend that folks should go out and take megadoses of alpha-lipoic acid,” said Costello. “The study is looking at the potential benefit of the supplement.”
“Taking large quantities of alpha-lipoic acid could affect blood sugar levels” she warned. “Eating a heart healthy diet is a good way to go, getting nutrients needed by eating healthy. Obesity, diabetes, and other comorbidities don’t do as well with MS, so get healthy, heart healthy.”
“This small study adds to previous reports in both animal models of MS and a few human trials, that lipoic acid may have beneficial effects in MS,” Dr. Barbara Giesser, professor of clinical neurology at the David Geffen School of Medicine at the University of California Los Angeles and clinical director of the UCLA multiple sclerosis program, told Healthline. “In this case, on preserving some mobility parameters in persons with secondary progressive MS.”
“Lipoic acid may be of benefit for persons with MS and appears to be well tolerated. Further and larger studies of this agent seem warranted.” Giesser said.